Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$98.56 - $119.91 $46,027 - $55,997
-467 Closed
0 $0
Q3 2021

Nov 09, 2021

BUY
$91.91 - $110.37 $5,238 - $6,291
57 Added 13.9%
467 $51,000
Q2 2021

Jul 22, 2021

BUY
$86.24 - $95.92 $6,985 - $7,769
81 Added 24.62%
410 $38,000
Q1 2021

Apr 20, 2021

SELL
$71.83 - $95.48 $5,961 - $7,924
-83 Reduced 20.15%
329 $30,000
Q4 2020

Feb 02, 2021

SELL
$67.0 - $84.39 $8,844 - $11,139
-132 Reduced 24.26%
412 $30,000
Q1 2020

Apr 22, 2020

BUY
$24.87 - $38.56 $1,144 - $1,773
46 Added 9.24%
544 $16,000
Q4 2019

Feb 03, 2020

BUY
$25.43 - $36.67 $12,664 - $18,261
498 New
498 $18,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Evolution Wealth Advisors, LLC Portfolio

Follow Evolution Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.